AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Talgesic 0.6mg Injection

Prescription Icon
Prescription Required

Marketer

Indus Pharma Pvt Ltd

Salt Composition

Buprenorphine (0.6mg)

Overview Talgesic 0.6mg Injection

Buprenorphine injection (0.6mg) is indicated for managing moderate to severe pain and opioid addiction in patients concurrently enrolled in comprehensive medical, social, and psychological programs. This medication is contraindicated for individuals under 16 years of age. Administration should be exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and treatment length are individualized based on therapeutic response and indication. Discontinuation should only occur under the supervision of a physician. Frequently reported adverse effects comprise fatigue, opioid withdrawal symptoms, apprehension, restlessness, vertigo, cephalalgia, somnolence, bowel looseness, nausea, emesis, and stomach discomfort. Persistent or worsening side effects necessitate immediate medical consultation; strategies for mitigation may be discussed. Prior to initiation, disclose any pre-existing respiratory, cardiac, hepatic, or renal conditions to your physician. Complete disclosure of all concomitant medications is crucial due to potential drug interactions. Pregnant or breastfeeding individuals should seek medical counsel before commencing treatment. Long-term therapy may necessitate regular monitoring of renal and hepatic function, and blood component levels.

Primary Ingredients of Talgesic 0.6mg Injection

No text provided. Please provide the text you would like me to rephrase.

Uses of Talgesic 0.6mg Injection

Morphine addiction: Management of moderate to severe pain

Major Benefits of Talgesic 0.6mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Talgesic 0.6mg Injection:

  • Headache
  • Back pain
  • Drowsiness
  • Vomiting
  • Drug withdrawal syndrome
  • Insomnia (difficulty in sleeping)
  • Dizziness
  • Sleepiness
  • Abdominal pain
  • Weakness
  • Sweating
  • Constipation
  • Withdrawal syndrome
  • Infection
  • Vertigo
  • Inflammation of the nose
  • Chills
  • Flu-like symptoms
  • Nausea

How to use Talgesic 0.6mg Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Talgesic 0.6mg Injection works:

Butrans 0.6mg Injection, a partial opioid agonist, alleviates pain by modulating specific brain receptors, thus altering pain perception and response.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Talgesic 0.6mg Injection and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Talgesic 0.6mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of 0.6mg Talgesic Injection while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administering Talgesic 0.6mg Injection may induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects are experienced.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the administration of 0.6mg Talgesic Injection requires careful monitoring. Dosage modification of 0.6mg Talgesic Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should receive Talgesic 0.6mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Talgesic 0.6mg Injection is contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Talgesic 0.6mg Injection :

NA

Facts to Know About Talgesic 0.6mg Injection

LabelValue
Chemical Category Phenanthrene Derivatives
Developing Habits Affirmative.
Treatment Category Neuroscience of the Central Nervous System
Action Class Partial Opioid Agonists

FAQs on Talgesic 0.6mg Injection

Talgesic 0.6mg Injection provides relief from severe pain unresponsive to or intolerant of other analgesics. It's unsuitable for mild or intermittent pain, or for pain requiring only occasional treatment. This medication also treats opioid use disorder.
Administer this medication via subcutaneous injection only; intravenous or intramuscular injection is strictly prohibited. Injecting Talgesic 0.6mg Injection intravenously or intramuscularly risks severe skin and tissue damage, potentially leading to a fatal blood clot.
Pain relief from intravenous administration typically begins within 10 to 30 minutes, reaching its peak effect within an hour.
Talgesic 0.6mg Injection typically provides pain relief for about six hours, although individual experiences may differ.
You may notice a small lump at the injection site; this is normal and may persist for several weeks, gradually diminishing in size. Avoid rubbing, massage, or tight clothing on the area. Contact your doctor if concerned.
Seek immediate medical attention if you experience slow, labored breathing with pauses, bluish lips, or unresponsiveness.
This medication can induce drowsiness or dizziness, impairing your ability to drive or use machinery. Refrain from alcohol consumption and contact your physician if you have any concerns.
This medication can significantly lower your blood pressure, potentially causing dizziness when standing up after sitting, particularly if you're also taking anti-hypertensive drugs. Consult your doctor; your dosage may need adjustment.
Prolonged use of this medication can lead to physical and psychological dependence, potentially resulting in withdrawal symptoms upon cessation.
Using Talgesic 0.6mg Injection during pregnancy risks your baby developing a dependence that may lead to life-threatening withdrawal symptoms after birth. Newborns experiencing such withdrawal may require several weeks of medical care.
Talgesic 0.6mg Injection may transfer to breast milk, potentially causing drowsiness or breathing difficulties in infants. Consult your doctor thoroughly regarding the associated risks.
Talgesic 0.6mg Injection, an opioid partial agonist-antagonist, provides pain relief. As a controlled substance with addictive potential, alternative pain management should be discussed with your doctor if addiction develops.
Talgesic 0.6mg injections counteract the effects of opiates.
Depression is not a known side effect of Talgesic 0.6mg Injection. Report any depressive symptoms to your doctor.
Talgesic 0.6mg Injection
13
MRP 16
17% off